Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Baricitinib Tablets

Approval Number

国药准字H20234188

Company南京力博维制药有限公司

Registration Date

September 28, 2023

Drug Information

Generic Name

巴瑞替尼片

Dosage Form

片剂

Strength

2mg

Drug Type

化学药品

Registration Date

September 28, 2023

Company Information

Applicant Company

Company Name南京力博维制药有限公司

Company Address

南京市江北新区长芦街道崇福璐310号

Manufacturing Company

Company Name南京优科制药有限公司

Company Address

南京经济技术开发区恒竞路28号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

巴瑞替尼片 - NMPA 批准文号 | MedPath